Identification of IDH and TERTp mutation status using 1H‐MRS in 112 hemispheric diffuse gliomas
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.26964
Abstract: There is a growing interest in noninvasively defining molecular subsets of hemispheric diffuse gliomas based on the isocitrate dehydrogenase (IDH) and telomerase reverse transcriptase gene promoter (TERTp) mutation status, which correspond to distinct tumor entities,… read more here.
Keywords: mutation status; hemispheric diffuse; tertp mutation; diffuse gliomas ... See more keywords
Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-13272-9
Abstract: Astrocytic tumours are the most common type of primary malignant brain tumour. Most astrocytic tumours will recur at some point after surgery. Currently, the combination of radiotherapy and chemotherapy does not prevent the recurrence of… read more here.
Keywords: idh1 tp53; mgmt atrx; astrocytic tumours; tertp mutation ... See more keywords
TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-89906-w
Abstract: Cutaneous basal cell carcinoma (cBCC) is an economic burden to health services, due to its great morbidity and increasing incidence in old people. Infiltrative cBCCs and cBCCs with micronodular pattern are considered as more aggressive.… read more here.
Keywords: cbccs; tertp mutation; expression; p53 expression ... See more keywords